ResearchDx Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ResearchDx's estimated annual revenue is currently $5.9M per year.(i)
  • ResearchDx's estimated revenue per employee is $155,000

Employee Data

  • ResearchDx has 38 Employees.(i)
  • ResearchDx grew their employee count by -24% last year.

ResearchDx's People

NameTitleEmail/Phone
1
Principal and Co-FounderReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
CFO / ControllerReveal Email/Phone
4
VP, Business DevelopmentReveal Email/Phone
5
Research scientist IIIReveal Email/Phone
6
PrincipalReveal Email/Phone
7
Senior Data ScientistReveal Email/Phone
8
Regulatory Specialist IIReveal Email/Phone
9
Research Associate IIIReveal Email/Phone
10
Regulatory Affairs Specialist IIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is ResearchDx?

ResearchDx is a Contract Diagnostics Organization (CDO) for the biopharmaceutical and diagnostic industries. We provide integrated, flexible services for the in vitro diagnostic development process. We are a complete end-to-end diagnostics solution. From initial assay conceptualization, discovery, optimization and validation in a CAP/CLIA laboratory environment, through a complete set of clinical research services and on to regulatory approval, ResearchDx provides the solutions to meet complex diagnostics development needs. Our expertise includes assay research and development, clinical laboratory services, clinical research, diagnostic manufacturing, and consulting.

keywords:N/A

N/A

Total Funding

38

Number of Employees

$5.9M

Revenue (est)

-24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4M38-32%$15M
#2
$4M386%N/A
#3
$6.4M383%N/A
#4
$8.8M383%N/A
#5
$8.8M380%N/A